Stay updated on Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.

Latest updates to the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page
- Check3 days agoChange DetectedNew latest revision v3.5.3 is added to the history, replacing the previous v3.5.2. This reflects a minor metadata update to the ClinicalTrials.gov record.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision v3.5.2 was added and v3.5.0 was removed in the page's history.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedRevision: v3.5.0 is active on the page, replacing v3.4.3 as part of a site-wide update to the UI and underlying system.SummaryDifference0.0%

- Check53 days agoChange DetectedA new revision entry v3.4.3 was added to the history and the v3.4.2 entry was removed.SummaryDifference0.0%

- Check60 days agoChange DetectedStudy Status updated to Completed on 2026-02-25 and Recruitment Status added on 2026-02-12. The previous status 'Active, not recruiting' was removed on 2025-10-24.SummaryDifference0.2%

- Check81 days agoChange DetectedRevision: v3.4.2 was added and the notice about government funding lapse, as well as Revision: v3.4.1, were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.